- Precipio (PRPO, Financial) urges shareholders to vote by June 16, 2025, to meet the quorum for the upcoming Annual Shareholders Meeting.
- Only 42% of shares have been voted, falling short of the 50% required quorum.
- Failure to reach quorum could lead to a rescheduling expense of up to $100,000.
Precipio, Inc. (PRPO), a specialty cancer diagnostics company, is making an urgent appeal to its shareholders to vote their shares by 11 PM Eastern Time on June 16, 2025. This action is crucial to meet the 50% quorum requirement for the Annual Shareholders Meeting scheduled for June 17, 2025, at 10 AM Eastern Time. As of the latest reports, only 42% of the shares have been voted.
The company highlights the financial implications of not meeting the quorum. Should the meeting be adjourned due to insufficient votes, Precipio would incur additional costs of up to $100,000 for rescheduling, which is significantly higher than the current meeting expense of less than $5,000. These added costs would encompass the hiring of a proxy solicitor, along with legal and administrative fees.
Management stresses the importance of shareholder participation, whether voting for or against the proposals. This participation is pivotal not only to avoid unnecessary expenditures but also to ensure that important corporate governance decisions are not delayed due to an adjournment.
Precipio is committed to addressing cancer misdiagnoses through its diagnostic products and services aimed at improving patient outcomes and reducing healthcare costs. For more information on Precipio's initiatives, visit their official website.
